NCT04930809View on ClinicalTrials.gov

Single and Multiple Dose Study of VER-01 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 25, 2021

Primary Completion Date

July 4, 2022

Study Completion Date

July 11, 2022

Conditions
Healthy
Interventions
DRUG

VER-01

standardised cannabis extract (containing 21 mg THC per gram drug product)

Trial Locations (1)

1090

University of Medicine in Vienna - Department of Clinical Pharmacology, Vienna

All Listed Sponsors
lead

Vertanical GmbH

INDUSTRY

NCT04930809 - Single and Multiple Dose Study of VER-01 in Healthy Volunteers | Biotech Hunter | Biotech Hunter